RG 7854Alternative Names: RG7854
Latest Information Update: 11 Feb 2017
At a glance
- Originator Roche
- Class Antivirals
- Mechanism of Action Toll-like receptor 7 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Hepatitis B
Most Recent Events
- 31 Dec 2016 Phase-I clinical trials in Hepatitis B (unspecified route) (Roche Presentation, February 2017)